contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-asa-key-information-relating-to-the-subsequent-offering-9

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Aqua Bio Technology is a Norwegian company operating in the cosmetics industry. The company develops, manufactures and commercializes ingredients that are used in various cosmetic products worldwide. The largest business is in solutions for skin care products. Most of the company's products are sold on a global market through various distributors. The company was founded in 2004 and has its headquarters in Lysaker.

Aqua Bio Technology

Reference is made to the announcement by Aqua Bio Technology ASA on 12 February 2026 concerning the successful placement of the conditional private placement (the "Private Placement") with total...

<div class="mfn-body">Reference is made to the announcement by Aqua Bio Technology ASA on 12 February 2026 concerning the successful placement of the conditional private placement (the "Private Placement") with total gross proceeds of NOK 10 million, and a contemplated subsequent offering (the "Subsequent Offering"). &nbsp; Key information for the Subsequent Offering is set out below: &nbsp; Date on which the terms of the Subsequent Offering was announced: 12 February 2026 &nbsp; Last day including right: 12 February 2026 &nbsp; First day excluding right: 13 February 2026 &nbsp; Record date: 16 February 2026 &nbsp; Maximum number of new shares: 800,000 &nbsp; Subscription price: NOK 5.00 &nbsp; Shall the rights be listed: No &nbsp;The issuance of new shares in the Subsequent Offering (the "Offer Shares") will be subject to grant of a board authorization to increase the share capital, as well as completion of the Private Placement, and the Company reserves the right in its sole discretion to not conduct or cancel the Subsequent Offering.&nbsp; This information is published in accordance with the requirements of the Continuing Obligations in Euronext Rule Book II.</div><div class="mfn-footer mfn-contacts mfn-76be5d61d270">Contacts Kristian Flaten CEO &amp; CFO Aqua Bio Technology ASAPhone: +47 9509 2322 Email: <a rel="noopener" href="mailto:kf@aquabiotech.no">kf@aquabiotech.no</a></div><div class="mfn-footer mfn-about mfn-4705b2e2e705">About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.This notice is published by Kristian Flaten on the listed date and time. </div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar-nsta">This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-12 23:56 CET.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments <a rel="noopener" href="https://storage.mfn.se/bdd5b09b-e18d-44e3-afcc-1b672aa4d608/aqua-bio-technology-asa-key-information-relating-to-the-subsequent-offering.pdf" class="mfn-generated mfn-primary">Aqua Bio Technology ASA: Key information relating to the Subsequent Offering</a></div>